113 related articles for article (PubMed ID: 15286164)
1. The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.
Müller JS; Abicht A; Burke G; Cossins J; Richard P; Baumeister SK; Stucka R; Eymard B; Hantaï D; Beeson D; Lochmüller H
J Med Genet; 2004 Aug; 41(8):e104. PubMed ID: 15286164
[No Abstract] [Full Text] [Related]
2. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.
Richard P; Gaudon K; Andreux F; Yasaki E; Prioleau C; Bauché S; Barois A; Ioos C; Mayer M; Routon MC; Mokhtari M; Leroy JP; Fournier E; Hainque B; Koenig J; Fardeau M; Eymard B; Hantaï D
J Med Genet; 2003 Jun; 40(6):e81. PubMed ID: 12807980
[No Abstract] [Full Text] [Related]
3. Lack of founder haplotype for the rapsyn N88K mutation: N88K is an ancient founder mutation or arises from multiple founders.
Ohno K; Engel AG
J Med Genet; 2004 Jan; 41(1):e8. PubMed ID: 14729848
[No Abstract] [Full Text] [Related]
4. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
[TBL] [Abstract][Full Text] [Related]
5. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
[TBL] [Abstract][Full Text] [Related]
6. Common founder effect of rapsyn N88K studied using intragenic markers.
Dunne V; Maselli RA
J Hum Genet; 2004; 49(7):366-369. PubMed ID: 15252722
[TBL] [Abstract][Full Text] [Related]
7. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil.
Estephan EP; Zambon AA; Marchiori PE; da Silva AMS; Caldas VM; Moreno CAM; Reed UC; Horvath R; Töpf A; Lochmüller H; Zanoteli E
Neuromuscul Disord; 2018 Nov; 28(11):961-964. PubMed ID: 30266223
[TBL] [Abstract][Full Text] [Related]
8. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.
Müller JS; Abicht A; Christen HJ; Stucka R; Schara U; Mortier W; Huebner A; Lochmüller H
Neuromuscul Disord; 2004 Nov; 14(11):744-9. PubMed ID: 15482960
[TBL] [Abstract][Full Text] [Related]
9. Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
Kumar A; Asghar S; Kavanagh R; Wicklund MP
Muscle Nerve; 2018 Oct; 58(4):E23-E24. PubMed ID: 30028532
[No Abstract] [Full Text] [Related]
10. [Congenital myasthenic syndromes due to mutations in the rapsyn gene].
Eymard B; Ioos C; Barois A; Estournet B; Mayer M; Fournier E; Yasaki E; Prioleau C; Bauché S; Gaudon K; Leroy JP; Koenig J; Richard P; Hantaï D
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S78-84. PubMed ID: 15269664
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia.
Gentili A; Ansaloni S; Morello W; Cecini MT; Cordelli DM; Baroncini S
Eur J Anaesthesiol; 2011 Oct; 28(10):748-9. PubMed ID: 21372719
[No Abstract] [Full Text] [Related]
12. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
[TBL] [Abstract][Full Text] [Related]
13. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
Brugnoni R; Maggi L; Canioni E; Moroni I; Pantaleoni C; D'Arrigo S; Riva D; Cornelio F; Bernasconi P; Mantegazza R
J Neurol; 2010 Jul; 257(7):1119-23. PubMed ID: 20157724
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
15. Decrement with high frequency repetitive nerve stimulation in a RAPSN congenital myasthenic syndrome.
LoRusso SJ; Iyadurai SJ
Muscle Nerve; 2018 Mar; 57(3):E106-E108. PubMed ID: 29053879
[No Abstract] [Full Text] [Related]
16. Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations.
Maselli R; Dris H; Schnier J; Cockrell J; Wollmann R
Clin Genet; 2007 Jul; 72(1):63-5. PubMed ID: 17594401
[No Abstract] [Full Text] [Related]
17. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.
Ohno K; Sadeh M; Blatt I; Brengman JM; Engel AG
Hum Mol Genet; 2003 Apr; 12(7):739-48. PubMed ID: 12651869
[TBL] [Abstract][Full Text] [Related]
18. Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.
Gaudon K; Pénisson-Besnier I; Chabrol B; Bouhour F; Demay L; Ben Ammar A; Bauché S; Vial C; Nicolas G; Eymard B; Hantaï D; Richard P
J Med Genet; 2010 Dec; 47(12):795-6. PubMed ID: 20930056
[TBL] [Abstract][Full Text] [Related]
19. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
Banwell BL; Ohno K; Sieb JP; Engel AG
Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome.
Leshinsky-Silver E; Shapira D; Yosovitz K; Ginsberg M; Lerman-Sagie T; Lev D
J Neurol Sci; 2012 May; 316(1-2):112-5. PubMed ID: 22326364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
